Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine (AN+AD) for Advanced Stage Classic Hodgkin Lymphoma: Updated Efficacy and Safety Results from the Single-Arm Phase 2 Study (SGN35-027 Part B)
| Autor: | Lee, Hun *, Flinn, Ian W., Melear, Jason, Ramchandren, Rod, Friedman, Judah *, Burke, John M., Linhares, Yuliya *, Gonzales, Paul Alan *, Raval, Mihir *, Chintapatla, Rangaswamy, Feldman, Tatyana, Yimer, Habte, Islas-Ohlmayer, Miguel *, Dean, Asad *, Rana, Vishal *, Gandhi, Mitul, Renshaw, John *, Ho, Linda, Fanale, Michelle A., Guo, Wenchuan *, Yasenchak, Christopher A. |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:763-765 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|